B44.1

Clinical Causes: Exposure to a high concentration of Aspergillus spores in the environment, especially in areas with mold or decaying organic matter Pre-existing lung diseases such as tuberculosis, bronchiectasis, or chronic obstructive pulmonary disease (COPD) Weakened immune system due to conditions like leukemia, lymphoma, or immunosuppressive therapies such as chemotherapy or corticosteroids Inhalation of Aspergillus spores during construction or renovation activities in healthcare settings or homes Previous lung injury or surgery increasing susceptibility to fungal colonization

Key Symptoms: Chronic cough, sometimes producing blood-streaked sputum Shortness of breath or wheezing Chest pain or discomfort Fever and night sweats Unexplained weight loss Fatigue or general feeling of illness Recurrent respiratory infections that do not respond to standard treatments

Diagnosis Path: Chest X-ray or computed tomography (CT) scan to identify characteristic lung lesions or fungal balls Sputum analysis and fungal cultures to detect Aspergillus species Serological tests measuring Aspergillus-specific antibodies or antigens Bronchoscopy with biopsy or sampling of lung tissue may be performed if needed Pulmonary function tests to assess the extent of lung impairment

Treatment Protocols: Antifungal medications such as voriconazole, itraconazole, or amphotericin B, prescribed based on severity and specific patient factors Corticosteroids may be used in cases involving allergic components or to reduce inflammation Surgical intervention might be necessary to remove localized fungal masses or damaged tissue Management of underlying lung conditions to minimize further fungal colonization Regular monitoring through follow-up imaging and lab tests to assess treatment effectiveness